CRISPR Therapeutics (CRSP) Income Annual - Discounting Cash Flows
CRISPR Therapeutics AG
CRSP (NASDAQ)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Report Filing 2024-02-21 2023-02-21 2022-02-15 2021-02-16 2020-02-12 2019-02-25 2018-03-08 2017-03-10 2015-12-31 2014-12-31
Revenue
370 0.44 913 0.54 290 3.12 41.0 5.16 0.25 0.00
Cost of Revenue
130 110 18.0 269 179 114 69.8 42.2 12.6 1.51
Gross Profit
240 -110 895 -269 110 -111 -28.8 -37.1 -12.3 -1.51
Operating Expenses
462 563 522 85.6 63.5 48.3 35.8 31.1 13.4 5.11
Research & Development
387 462 439 267 179 114 69.8 42.2 12.6 1.51
Selling, General and Administrative
76.2 102 103 88.2 63.5 48.3 35.8 31.1 13.4 5.11
Other Operating Expenses
-1.21 -0.76 -19.8 -270 -179 -114 -69.8 -42.2 -12.6 -1.51
Operating Income
-223 -673 374 -354 46.7 -159 -64.6 -68.1 -25.7 -6.63
Net Non-Operating Interest
0.00 69.5 0.00 0.00 10.0 0.00 0.00 -8.05 -0.11 0.00
Interest Income
0.00 22.7 0.00 0.00 10.0 0.00 0.00 0.00 0.00 0.00
Interest Expense
0.00 -46.8 0.00 0.00 0.00 0.00 0.00 8.05 0.11 0.00
Equity & Other Income/(Expense)
71.8 -46.8 6.00 6.38 10.5 -5.48 -1.96 53.5 0.02 -0.24
Income Before Tax
-151 -650 380 -348 67.3 -164 -66.6 -22.7 -25.8 -6.86
Income Tax Expense
2.89 -0.32 1.87 0.81 0.45 0.55 1.75 0.48 0.01 -0.06
Income Attributable to Non-Controlling Interest
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Income
-154 -650 378 -349 66.9 -165 -68.4 -23.2 -25.8 -6.80
Depreciation and Amortization
19.8 24.2 18.0 9.18 4.72 3.52 3.02 1.00 0.13 0.04
EBITDA
-203 -649 391 -345 51.5 -155 -61.6 -67.1 -25.6 -6.59
Earnings Per Share (EPS)
-1.940 -8.360 4.970 -5.290 1.230 -3.440 -1.710 -1.890 -0.880 -0.230
Diluted Earnings Per Share
-1.940 -8.360 4.700 -5.290 1.170 -3.440 -1.710 -1.890 -0.880 -0.230
Weighted Average Shares Outstanding
79.2 77.7 75.9 65.9 54.4 48.0 40.0 12.3 29.3 29.3
Diluted Weighted Average Shares Outstanding
79.2 77.7 80.4 65.9 56.9 48.0 40.1 12.3 29.3 29.3
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us